GoodRx Holdings, Inc. (GDRX) Form 8-K Summary

GoodRx filed this Form 8-K on November 4, 2025, primarily to announce financial results.

• Event: Item 2.02 reports the Company’s financial results for the three and nine months ended September 30, 2025.
• Key Disclosure: The actual financial metrics are not contained in the 8-K body but are furnished via the press release attached as Exhibit 99.1.
• Management Signature: Signed by Christopher McGinnis, CFO & Treasurer.

Investors must refer to Exhibit 99.1 for substantive financial performance data, strategic